Related Experiment Video

Updated: May 15, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Attenuation of tumor growth by honokiol: an evolving role in oncology

S Kapoor

    Drug Discoveries & Therapeutics
    |January 23, 2013
    PubMed

    Insights

    Honokiol shows potential in treating systemic tumors, including mammary malignancies. This natural compound works by activating AMPK, which reduces tumor cell proliferation and growth.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Pharmacology

    Background:

    • Honokiol, a compound found in Magnolia species, is being investigated for its broad-spectrum therapeutic potential.
    • Existing research highlights honokiol's antineoplastic effects, particularly in skin cancers.
    • This study explores honokiol's efficacy in non-skin systemic tumors, specifically mammary malignancies.

    Discussion:

    • Honokiol demonstrates significant antineoplastic effects in mammary tumors.
    • The compound's mechanism involves the modulation of key cellular pathways.
    • Specifically, honokiol enhances the phosphorylation of AMP-activated protein kinase (AMPK).

    Key Insights:

    • Honokiol attenuates tumor growth and proliferation in mammary malignancies.
    • AMPK activation by honokiol is a critical mediator of its anti-tumor effects.
    • These findings suggest honokiol's potential beyond skin cancer treatment.

    Outlook:

    • Further research is warranted to elucidate honokiol's full therapeutic potential in various systemic cancers.
    • Investigating honokiol's synergistic effects with conventional therapies could enhance treatment strategies.
    • Clinical trials may be considered to evaluate honokiol's safety and efficacy in human patients.

    More Related Videos

    Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

    Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

    Published on: June 26, 2018

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...